EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) under the Securities Exchange
Act of 1934, as amended, the persons named below agree to the joint filing on
behalf of each of them of a statement on Schedule 13D (including amendments
thereto) with respect to the Common Stock, par value $.01 per share of Immulogic
Pharmaceutical Corporation and further agree that this Joint Filing Agreement be
included as an Exhibit to such joint filings. In evidence thereof, the
undersigned, being duly authorized, have executed this Joint Filing Agreement
this 7th day of September, 1999.
Dated: September 7, 1999
By: /s/ Xxxx X. Icahn
Xxxx X. Icahn
RIVERDALE LLC
By: /s/ Xxxx X. Icahn
Xxxx X. Icahn
Manager
HIGH RIVER LIMITED PARTNERSHIP
By: Riverdale LLC
By: /s/ Xxxx X. Icahn
Xxxx X. Icahn
Manager
(Signature page of Schedule 13D - Joint Filing Agreement for
Immulogic Pharmaceutical Corporation)
